4
Changes in Ownership
Immuneering Corp Filed Acc 0001790340-26-000082
Options or other derivatives
- Chief Financial Officer acquired 650,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gengos Andrew · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-16 | Grant or award : show line 1 in the form Stock Option | +650,000 | 650,000 | D |
Loading xslF345X06/wk-form4_1784320143.xml…